King Abdulaziz City for Science and Technology (KACST) today celebrated Professor Omar Yaghi, winner of the 2025 Nobel Prize ...
Seeking biotech investment, breakthrough innovations, or a strategic gateway to the Asia-Pacific? The answers await in Hong ...
Swiss pharma heavyweight Novartis is cutting a very large check. The company has agreed to acquire London-headquartered ...
Sofinnova Partners, a leading European life sciences venture capital firm, today announced that its portfolio company Myricx Bio (“Myricx”) has reached agreement to be acquired by Novartis, for up to ...
Cambridge-based cell programming company bit.bio has introduced two new media kits for its iPSC-derived ioGlutamatergic ...
Novartis will pay $1.1bn upfront and up to $400m in milestones for Myricx Bio, a UK firm developing a novel payload for antibody-drug conjugates.
Stocks: European shares were mostly higher on Monday, as semiconductor stocks lost momentum but other sectors rallied. Approaching midday, the Stoxx 600, the DAX, t ...
Strengthens the Novartis oncology pipeline with two lead ADC assets and a broader payload platform with potential impact ...
During the convention, Jyong Biotech presented its botanical new drug candidate, Botreso® (API-1), to international pharmaceutical companies as the Company continues advancing global licensing ...
Dr. Albert B. Sabin gave away his oral polio vaccine for free, but the first biography on the scientist presents a man of ...
Publisher’s Weekly has spoken. The weekly trade news magazine for publishers, librarians, booksellers and literary agents has ...
What makes something alive? We simply don't know, but synthetic biologists are a step closer to providing an answer thanks to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results